The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors
Maram AlShammari,1 Ghadah Assiri,1 Mohammed bin Buraykan,1 Yasser Almogbel,2 Azher Arafah,1,3 Adel Bashatah,4 Yazed AlRuthia1,5 1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2Department of Pharmacy Practice, College of Pharmacy, Qassim University,...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/the-impact-of-direct-to-consumer-pharmaceutical-advertising-on-public--peer-reviewed-article-PPA |
id |
doaj-9654bb224d1f4edeb91bedfea6790a14 |
---|---|
record_format |
Article |
spelling |
doaj-9654bb224d1f4edeb91bedfea6790a142020-11-25T03:29:41ZengDove Medical PressPatient Preference and Adherence1177-889X2020-03-01Volume 1463564252631The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump InhibitorsAlShammari MAssiri Gbin Buraykan MAlmogbel YArafah ABashatah AAlRuthia YMaram AlShammari,1 Ghadah Assiri,1 Mohammed bin Buraykan,1 Yasser Almogbel,2 Azher Arafah,1,3 Adel Bashatah,4 Yazed AlRuthia1,5 1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraidah, Saudi Arabia; 3Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia; 4Department of Nursing Education and Administration, College of Nursing, King Saud University, Riyadh, Saudi Arabia; 5Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Yazed AlRuthiaDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaTel +996 114677483Fax +966 114677480Email yazeed@ksu.edu.saBackground: The use of direct-to-consumer advertising (DTCA) to promote sales of over-the-counter (OTC) pharmaceuticals used to manage common medical conditions, such as gastroesophageal reflux disease (GERD), is increasing. However, the educational value of these advertisements as well as the public perceptions of this type of advertising remain largely unknown among non-English speaking populations.Objective: The aim of this study was to explore the public perceptions and educational value of a short motion graphic video documenting the lifestyle of person with GERD and presenting a brief introduction to the role of proton pump Inhibitors (PPIs) in relieving the symptoms.Methods: This was a prospective quasi-experimental study in which a short mock advertising motion graphic video was shown to a sample of adult individuals in malls and shopping centers in different cities across Saudi Arabia. Participants were required to express their levels of agreement with six statements concerning their perceptions of DTCA of OTC drugs, and answer a quiz consisting of three questions and enquiries about their knowledge of GERD and the OTC drugs used in its treatment.Results: Two hundred and ninety-five participants were involved in this study, the majority of whom were female (55.30%). After watching the video, the percentages of participants who strongly agreed or agreed that DTCA is a credible source of information and encourages them to purchase the marketed drug have increased significantly (P< 0.05). With regard to the quiz, the percentages of participants with correct answers regarding the definition of GERD, knowledge of OTC drugs for GERD, and awareness of the common side effects of PPIs increased from 81.69% to 95.93%, 69.83% to 96.27%, and 46.44% to 91.53%, respectively (P< 0.0001).Conclusion: DTCA of OTC drugs for GERD, particularly if the content complies with the regulatory requirements, can promote the public knowledge of the disease and treatment options.Keywords: direct-to-consumer advertising, gastroesophageal reflux, proton pump inhibitorshttps://www.dovepress.com/the-impact-of-direct-to-consumer-pharmaceutical-advertising-on-public--peer-reviewed-article-PPAdirect-to-consumer advertisinggastroesophageal refluxproton pump inhibitors |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
AlShammari M Assiri G bin Buraykan M Almogbel Y Arafah A Bashatah A AlRuthia Y |
spellingShingle |
AlShammari M Assiri G bin Buraykan M Almogbel Y Arafah A Bashatah A AlRuthia Y The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors Patient Preference and Adherence direct-to-consumer advertising gastroesophageal reflux proton pump inhibitors |
author_facet |
AlShammari M Assiri G bin Buraykan M Almogbel Y Arafah A Bashatah A AlRuthia Y |
author_sort |
AlShammari M |
title |
The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors |
title_short |
The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors |
title_full |
The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors |
title_fullStr |
The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors |
title_full_unstemmed |
The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors |
title_sort |
impact of direct-to-consumer pharmaceutical advertising on public knowledge of gastroesophageal reflux disease: a study on over-the-counter proton pump inhibitors |
publisher |
Dove Medical Press |
series |
Patient Preference and Adherence |
issn |
1177-889X |
publishDate |
2020-03-01 |
description |
Maram AlShammari,1 Ghadah Assiri,1 Mohammed bin Buraykan,1 Yasser Almogbel,2 Azher Arafah,1,3 Adel Bashatah,4 Yazed AlRuthia1,5 1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraidah, Saudi Arabia; 3Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia; 4Department of Nursing Education and Administration, College of Nursing, King Saud University, Riyadh, Saudi Arabia; 5Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Yazed AlRuthiaDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaTel +996 114677483Fax +966 114677480Email yazeed@ksu.edu.saBackground: The use of direct-to-consumer advertising (DTCA) to promote sales of over-the-counter (OTC) pharmaceuticals used to manage common medical conditions, such as gastroesophageal reflux disease (GERD), is increasing. However, the educational value of these advertisements as well as the public perceptions of this type of advertising remain largely unknown among non-English speaking populations.Objective: The aim of this study was to explore the public perceptions and educational value of a short motion graphic video documenting the lifestyle of person with GERD and presenting a brief introduction to the role of proton pump Inhibitors (PPIs) in relieving the symptoms.Methods: This was a prospective quasi-experimental study in which a short mock advertising motion graphic video was shown to a sample of adult individuals in malls and shopping centers in different cities across Saudi Arabia. Participants were required to express their levels of agreement with six statements concerning their perceptions of DTCA of OTC drugs, and answer a quiz consisting of three questions and enquiries about their knowledge of GERD and the OTC drugs used in its treatment.Results: Two hundred and ninety-five participants were involved in this study, the majority of whom were female (55.30%). After watching the video, the percentages of participants who strongly agreed or agreed that DTCA is a credible source of information and encourages them to purchase the marketed drug have increased significantly (P< 0.05). With regard to the quiz, the percentages of participants with correct answers regarding the definition of GERD, knowledge of OTC drugs for GERD, and awareness of the common side effects of PPIs increased from 81.69% to 95.93%, 69.83% to 96.27%, and 46.44% to 91.53%, respectively (P< 0.0001).Conclusion: DTCA of OTC drugs for GERD, particularly if the content complies with the regulatory requirements, can promote the public knowledge of the disease and treatment options.Keywords: direct-to-consumer advertising, gastroesophageal reflux, proton pump inhibitors |
topic |
direct-to-consumer advertising gastroesophageal reflux proton pump inhibitors |
url |
https://www.dovepress.com/the-impact-of-direct-to-consumer-pharmaceutical-advertising-on-public--peer-reviewed-article-PPA |
work_keys_str_mv |
AT alshammarim theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT assirig theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT binburaykanm theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT almogbely theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT arafaha theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT bashataha theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT alruthiay theimpactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT alshammarim impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT assirig impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT binburaykanm impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT almogbely impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT arafaha impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT bashataha impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors AT alruthiay impactofdirecttoconsumerpharmaceuticaladvertisingonpublicknowledgeofgastroesophagealrefluxdiseaseastudyonoverthecounterprotonpumpinhibitors |
_version_ |
1724577688117575680 |